Current Environment: Production

Jane Whitney | Medical Services

Programs & Services

Languages

  • English

Jane Whitney | Education

Undergraduate School

Wellesley College

2004, Wellesley, MA

Medical School

Stanford University School of Medicine

2012, Stanford, MA

Internship

Pediatrics

Boston Combined Residency Program (BCRP)

2013, Boston, MA

Residency

Pediatrics

Boston Combined Residency Program (BCRP)

2015, Boston, MA

Fellowship

Pediatric Critical Care

Children's Hospital of Philadelphia

2018, Philadelphia, PA

Graduate School

University of Pennsylvania

2019, Philadelphia, PA

Jane Whitney | Certifications

  • American Board of Pediatrics (Critical Care Medicine)
  • American Board of Pediatrics (General)

Jane Whitney | Publications

  1. Derivation and Validation of a Clinical and Endothelial Biomarker Risk Model to Predict Persistent Pediatric Sepsis-Associated Acute Respiratory Dysfunction. CHEST Crit Care. 2025 Mar; 3(1). View Derivation and Validation of a Clinical and Endothelial Biomarker Risk Model to Predict Persistent Pediatric Sepsis-Associated Acute Respiratory Dysfunction. Abstract

  2. Biomarker-Based Risk Stratification Tool in Pediatric Acute Respiratory Distress Syndrome: Single-Center, Longitudinal Validation in a 2014-2019 Cohort. Pediatr Crit Care Med. 2024 Jul 01; 25(7):599-608. View Biomarker-Based Risk Stratification Tool in Pediatric Acute Respiratory Distress Syndrome: Single-Center, Longitudinal Validation in a 2014-2019 Cohort. Abstract

  3. Evolution of multiple omics approaches to define pathophysiology of pediatric acute respiratory distress syndrome. Elife. 2022 08 01; 11. View Evolution of multiple omics approaches to define pathophysiology of pediatric acute respiratory distress syndrome. Abstract

  4. Endothelial Dysfunction Criteria in Critically Ill Children: The PODIUM Consensus Conference. Pediatrics. 2022 01 01; 149(1 Suppl 1):S97-S102. View Endothelial Dysfunction Criteria in Critically Ill Children: The PODIUM Consensus Conference. Abstract

  5. Endothelial Biomarkers Are Associated With Indirect Lung Injury in Sepsis-Associated Pediatric Acute Respiratory Distress Syndrome. Crit Care Explor. 2020 Dec; 2(12):e0295. View Endothelial Biomarkers Are Associated With Indirect Lung Injury in Sepsis-Associated Pediatric Acute Respiratory Distress Syndrome. Abstract

  6. Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor as Novel Biomarkers for Poor Outcomes in Children With Severe Sepsis and Septic Shock. Pediatr Emerg Care. 2020 Dec; 36(12):e715-e719. View Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor as Novel Biomarkers for Poor Outcomes in Children With Severe Sepsis and Septic Shock. Abstract

  7. Deployment of a Clinical Pathway to Improve Postcardiac Arrest Care: A Before-After Study. Pediatr Crit Care Med. 2020 10; 21(10):e898-e907. View Deployment of a Clinical Pathway to Improve Postcardiac Arrest Care: A Before-After Study. Abstract

  8. Systemic Endothelial Activation Is Associated With Early Acute Respiratory Distress Syndrome in Children With Extrapulmonary Sepsis. Crit Care Med. 2020 03; 48(3):344-352. View Systemic Endothelial Activation Is Associated With Early Acute Respiratory Distress Syndrome in Children With Extrapulmonary Sepsis. Abstract

  9. A Pilot Study of the Association of Amino-Terminal Pro-B-Type Natriuretic Peptide and Severity of Illness in Pediatric Septic Shock. Pediatr Crit Care Med. 2019 02; 20(2):e55-e60. View A Pilot Study of the Association of Amino-Terminal Pro-B-Type Natriuretic Peptide and Severity of Illness in Pediatric Septic Shock. Abstract

  10. Systemic Angiopoietin-1/2 Dysregulation in Pediatric Sepsis and Septic Shock. Int J Med Sci. 2019; 16(2):318-323. View Systemic Angiopoietin-1/2 Dysregulation in Pediatric Sepsis and Septic Shock. Abstract

  11. Socio-emotional processing and functioning of youth at high risk for bipolar disorder. J Affect Disord. 2013 May 15; 148(1):112-7. View Socio-emotional processing and functioning of youth at high risk for bipolar disorder. Abstract

  12. Elevated rates of ADHD in mothers of children with comorbid ADHD and epilepsy. Neuropsychiatry (London). 2012 Oct 01; 2(5):385-391. View Elevated rates of ADHD in mothers of children with comorbid ADHD and epilepsy. Abstract

  13. Information processing in adolescents with bipolar I disorder. J Child Psychol Psychiatry. 2012 Sep; 53(9):937-45. View Information processing in adolescents with bipolar I disorder. Abstract

  14. Acute liver failure in a pediatric patient with disseminated tuberculosis. Dig Dis Sci. 2011 Oct; 56(10):2780-3. View Acute liver failure in a pediatric patient with disseminated tuberculosis. Abstract

  15. Tolerability of atomoxetine for treatment of pediatric attention-deficit/hyperactivity disorder in the context of epilepsy. Epilepsy Behav. 2011 Jan; 20(1):95-102. View Tolerability of atomoxetine for treatment of pediatric attention-deficit/hyperactivity disorder in the context of epilepsy. Abstract

  16. Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy. Epilepsy Behav. 2010 Jul; 18(3):229-37. View Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy. Abstract

  17. An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy. Expert Opin Investig Drugs. 2008 Jan; 17(1):77-84. View An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy. Abstract

  18. Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment. Epilepsy Behav. 2008 Feb; 12(2):217-33. View Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment. Abstract

  19. Tolerability of selective serotonin reuptake inhibitors in thirty-nine children under age seven: a retrospective chart review. J Child Adolesc Psychopharmacol. 2007 Apr; 17(2):165-74. View Tolerability of selective serotonin reuptake inhibitors in thirty-nine children under age seven: a retrospective chart review. Abstract

  20. Psychiatric disorders and behavioral characteristics of pediatric patients with both epilepsy and attention-deficit hyperactivity disorder. Epilepsy Behav. 2007 May; 10(3):384-8. View Psychiatric disorders and behavioral characteristics of pediatric patients with both epilepsy and attention-deficit hyperactivity disorder. Abstract

BESbswy